Stocks 22 February 2026 - 27 February 2026

Liquidia Sinks 5% After Recent Rally

Liquidia Sinks 5% After Recent Rally

Liquidia Corporation shares were flat in early trading Tuesday after falling hard the day before. Investors are watching for more news from the company on YUTREPIA, its inhaled drug for lung disease. The Nasdaq stock ended Monday at $58.75, off 5.04%, and was last seen at $58.91 in thin premarket action at 6:22 a.m. EDT, according to MarketWatch. Liquidia has been a top biotech pick for 2026, with the stock gaining about 70% year to date through Monday, Yahoo Finance data show. Shares touched an intraday high of $63.46 last week before pulling back.
June 2, 2026
Cadence stock faces Tuesday test after Hexagon deal closes and new shares hit tape

Cadence stock faces Tuesday test after Hexagon deal closes and new shares hit tape

New York, Feb 24, 2026, 05:40 EST — Premarket Cadence Design Systems shares took a hit Monday, dropping 5.6% to finish at $279.80, as investors digested news of the company closing its acquisition of Hexagon’s design-and-engineering unit with a fresh stock issuance. The move pushes Cadence further out of its core chip tools niche and into the industrial simulation space.
February 24, 2026
1 4 5 6 7 8 9